Avista saw a positive improvement to its Relative Strength (RS) Rating on Thursday, rising from 67 to 77.
IBD's proprietary RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the last 52 weeks matched up against all other stocks.
History reveals that the top-performing stocks often have an RS Rating north of 80 in the early stages of their moves. See if Avista can continue to show renewed price strength and clear that threshold.
When To Sell Stocks To Lock In Profits And Minimize Losses
Avista broke out earlier, but has fallen back below the prior 39.98 entry from a flat base. If a stock you're watching climbs above a buy point then retreats 7% or more below the original entry price, it's considered a failed base. It's best to wait for the stock to form a new base and breakout. Also keep in mind that the latest consolidation is a later-stage base, which makes it riskier to establish a new position or add shares to an existing one.
Avista showed -21% EPS growth in the latest quarterly report. Sales rose 3%.
The company holds the No. 9 rank among its peers in the Utility-Diversified industry group. Ameren Corp, Chesapeake Utilities and Alliant Energy are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
